Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-047669

PHARMACYCLICS INC · PCYC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert W Duggan
Officer — Chairman and CEO · Director · 10% Owner
Period of report
May 26, 2015
Accepted (ET)
May 28, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000949699

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 17, 2015G152,635$0.00D13,230,316D
Common StockF1Mar 18, 2015G4,785$0.00D13,225,531D
Common StockF1,F2May 26, 2015U13,225,531$261.25D0D
Common StockF2,F3,F4May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3,F5May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3,F6May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3,F7May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3,F8May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3,F9May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3,F10May 26, 2015U21,908$261.25D0IBy Trust
Common StockF2,F3May 26, 2015U8,404$261.25D0IBy Child
Common StockF2,F3May 26, 2015U8,404$261.25D0IBy Child
Common StockF2,F3May 26, 2015U8,404$261.25D0IBy Child
Common StockF2,F3May 26, 2015U8,404$261.25D0IBy Child
Common StockF3May 26, 2015U8,404$261.25D0IBy Child
Common StockF2,F11May 26, 2015U170,379$261.25D0IManaged Accounts

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses